U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
CA9-SCAN CG250
Preferred Name English
GIRENTUXIMAB
INN   MART.   USAN   WHO-DD  
INN   USAN  
Official Name English
GIRENTUXIMAB [USAN]
Common Name English
RENCAREX
Brand Name English
girentuximab [INN]
Common Name English
Girentuximab [WHO-DD]
Common Name English
WX-G250
Code English
CG250
Code English
GIRENTUXIMAB [MART.]
Common Name English
CG-250
Code English
Classification Tree Code System Code
NCI_THESAURUS C129822
Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025
FDA ORPHAN DRUG 139000
Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025
NCI_THESAURUS C20401
Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025
FDA ORPHAN DRUG 133300
Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025
Code System Code Type Description
USAN
WW-150
Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025
PRIMARY
INN
9116
Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025
PRIMARY
ChEMBL
CHEMBL1743027
Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025
PRIMARY
CAS
916138-87-9
Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025
PRIMARY
NCI_THESAURUS
C1960
Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025
PRIMARY
WIKIPEDIA
Girentuximab
Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025
PRIMARY
DRUG BANK
DB05304
Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025
PRIMARY
EVMPD
SUB129650
Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025
PRIMARY
FDA UNII
539B57DFJF
Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025
PRIMARY
SMS_ID
100000155597
Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025
PRIMARY
ACTIVE MOIETY
GIRENTUXIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966